Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis
- PMID: 9627242
- DOI: 10.1016/S0194-5998(98)70274-8
Preliminary results of the use of indole-3-carbinol for recurrent respiratory papillomatosis
Abstract
Objective: We report the preliminary results of a phase I trial using indole-3-carbinol for the treatment of recurrent respiratory papillomatosis. Indole-3-carbinol is a chemical that is found in high concentrations in cruciferous vegetables and has been shown to alter the growth pattern of recurrent respiratory papillomatosis cell cultures and to be effective in an in vivo animal model of recurrent respiratory papillomatosis.
Methods: Eighteen patients were treated with oral indole-3-carbinol and had a minimum follow-up of 8 months and a mean follow-up of 14.6 months. All patients received indole-3-carbinol, and outcome measures included a change in papilloma growth rate and the need for surgery during treatment compared with before treatment. All patients had serial examinations with videoendoscopy to document papilloma location and growth rate.
Results: Thirty-three percent (6 of 18) of the study patients had a cessation of their papilloma growth and have not required surgery since the start of the study. Six patients have had reduced papilloma growth rate, and 6 (33%) patients have shown no clinical response to indole-3-carbinol. Indole-3-carbinol affects the ratio of hydroxylation of estradiol; changes in the ratios of urinary 2-hydroxylation and 16-hydroxylation of estradiol caused by indole-3-carbinol correlated well with clinical response. No major complications or changes in the children's growth curve were noted.
Conclusions: The preliminary results of treating recurrent respiratory papillomatosis with indole-3-carbinol holds promise. Longer follow-up of this patient group and a blinded, controlled trial are required. We conclude that indole-3-carbinol appears to be safe and well tolerated and may be an efficacious treatment for recurrent respiratory papillomatosis.
Similar articles
-
Treatment of Recurrent Respiratory Papillomatosis: Case Series and Review of Technique.Surg Technol Int. 2021 May 20;38:139-143. doi: 10.52198/21.STI.38.GS1408. Surg Technol Int. 2021. PMID: 33844241 Review.
-
Scientific and clinical aspects of the use of cidofovir in recurrent respiratory papillomatosis.Int J Pediatr Otorhinolaryngol. 2008 Jul;72(7):939-44. doi: 10.1016/j.ijporl.2008.04.003. Epub 2008 May 27. Int J Pediatr Otorhinolaryngol. 2008. PMID: 18502519 Review.
-
2',5'-Oligoadenylate synthetase activity analysis and human papilloma virus typing as prognostic factors in patients with recurrent respiratory papillomatosis.J Laryngol Otol. 2004 Oct;118(10):750-6. doi: 10.1258/0022215042450733. J Laryngol Otol. 2004. PMID: 15550179
-
Indole-3-carbinol for recurrent respiratory papillomatosis: long-term results.J Voice. 2004 Jun;18(2):248-53. doi: 10.1016/j.jvoice.2003.05.005. J Voice. 2004. PMID: 15193659 Clinical Trial.
-
Treatment of recurrent respiratory papillomatosis with indole-3-carbinol.Am J Otolaryngol. 1997 Jul-Aug;18(4):283-5. doi: 10.1016/s0196-0709(97)90012-0. Am J Otolaryngol. 1997. PMID: 9242883 No abstract available.
Cited by
-
Effectiveness of combined approach to recurrent respiratory papillomatosis (RRP).Eur Arch Otorhinolaryngol. 2024 Jul;281(7):3693-3700. doi: 10.1007/s00405-024-08653-6. Epub 2024 Apr 18. Eur Arch Otorhinolaryngol. 2024. PMID: 38637412
-
Natural Bioactives: Back to the Future in the Fight against Human Papillomavirus? A Narrative Review.J Clin Med. 2022 Mar 7;11(5):1465. doi: 10.3390/jcm11051465. J Clin Med. 2022. PMID: 35268556 Free PMC article. Review.
-
Molecular Mechanisms and Pathways as Targets for Cancer Prevention and Progression with Dietary Compounds.Int J Mol Sci. 2017 Sep 25;18(10):2050. doi: 10.3390/ijms18102050. Int J Mol Sci. 2017. PMID: 28946660 Free PMC article. Review.
-
Human papilloma virus vaccination in patients with an aggressive course of recurrent respiratory papillomatosis.Eur Arch Otorhinolaryngol. 2014 Dec;271(12):3255-62. doi: 10.1007/s00405-014-3143-y. Epub 2014 Jun 26. Eur Arch Otorhinolaryngol. 2014. PMID: 24964770
-
The safety of cruciferous plants in humans: a systematic review.J Biomed Biotechnol. 2012;2012:503241. doi: 10.1155/2012/503241. Epub 2012 Feb 22. J Biomed Biotechnol. 2012. PMID: 22500092 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical